Increased matrix metalloproteinase-9 activity in human ovarian cancer cells cultured with conditioned medium from human peritoneal tissue

Clinical and Experimental Metastasis

Volumn 15, Issue 6, 1997, Pages 612-619

  Shibata, Kiyosumi ^a   Kikkawa, Fumitaka ^a   Nawa, Akihiko ^a   Tamakoshi, Koji ^a   Suganuma, Nobuhiko ^a   Tomoda, Yutaka ^a  

^a NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Invasion; Matrix metalloproteinase; Mesothelial cells; Ovarian cancer cells; Peritoneal tissue

Indexed keywords

GELATINASE A; GELATINASE B;

ARTICLE; CANCER CELL; CELL CULTURE; CONTROLLED STUDY; CULTURE MEDIUM; ENZYME ACTIVITY; HUMAN; HUMAN CELL; HUMAN TISSUE; MESOTHELIUM CELL; OVARY CANCER; PERITONEUM;

COLLAGENASES; CULTURE MEDIA, CONDITIONED; EPITHELIUM; FEMALE; HUMANS; MATRIX METALLOPROTEINASE 9; MOLECULAR WEIGHT; OVARIAN NEOPLASMS; PERITONEUM; TUMOR CELLS, CULTURED;

EID: 0030800804     PISSN: 02620898     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1018495414975     Document Type: Article

References (32)

1. Marcel MM, De Baetselier P and Van Roy FM, 1991, Cellular activities implicated in invasion and metastasis. In: Mareel MM, De Baetselier P and Van Roy FM, eds. Mechanisms of Invasion and Metastasis. Boca Raton, FL: CRC Press, 73-219.
2. Liotta LA, Steeg PS and Stetler-Stevenson WG, 1991, Cancer metastasis and angiogenesis: an imbalance of positive and negative regulation. Cell, 64, 327-36.
3. r 95 000 type IV collagenase/gelatinase and interstitial fibroblast-type collagenase by rat mucosal keratinocytes. J Biol Chem, 25, 19143-51.
4. Fabunmi RP, Baker AH, Murray EJ, Booth RF and Newby AC, 1996, Divergent regulation by growth factors and cytokines of 95 kDa and 72 kDa gelatinases and tissue inhibitors or metalloproteinase-1,-2,-3 in rabbit aortic smooth muscle cells. Biochem J, 315, 335-42.
5. r 92,000 type IV collagenase expression in a squamous cell carcinoma cell line by fibroblasts. Cancer Res, 55, 963-7.
6. Goldberg GI, Strongin A, Collier IE, Genrich LT and Marmer BL, 1992, Interaction of 92-kDa type IV collagenase with the tissue inhibitor of metalloproteinases prevents dimerization, complex formation with interstitial collagenase, and activation of the proenzyme with stromelysin. J Biol Chem, 267, 4583-91.
7. Kurogi T, Nabeshima K, Kataoka H, Okada Y and Koono M, 1996, Stimulation of gelatinase B and tissue inhibitors of metalloproteinase (TIMP) production in co-culture of human osteosarcoma cells and human fibroblasts: gelatinase B production was stimulated via up-regulation of fibroblast growth factor (FGF) receptor. Int J Cancer, 66, 82-90.
8. Himelstein BP and Muschel RJ, 1996, Induction of matrix metalloproteinase 9 expression in breast carcinoma cells by soluble factor from fibroblast. Clin Exp Metastasis, 14, 197-208.
9. Nakajima M and Chop AM, 1991, Tumor invasion and extracellular matrix degradative enzymes: regulation of activity by organ factors. Sem Cancer Biol, 2, 115-27.
10. Nakajima M, Morikawa K, Fabra A, Bucana CO and Fidler IJ, 1990, Influence of organ environment on extracellular matrix degradative activity and metastasis of human colon carcinoma cells. J Natl Cancer Inst, 82, 1890-8.
11. Fabra A, Nakajima M, Bucana CD and Fidler IJ, 1992, Modulation of the invasive phenotype of human colon carcinoma cells by organ specific fibroblasts of nude mice. Differentiation, 52, 101-10.
12. Gohji K, Nakajima M, Fabra A, et al. 1994, Regulation of gelatinase production in metastatic renal cell carcinoma by organ-specific fibroblasts. Jpn J Cancer Res, 85, 152-60.
13. Gohji K, Fidler IJ, Tsan R, et al. 1994, Human recombinant interferons-beta and -gamma decrease gelatinase production and invasion by human KG-2 renal-carcinoma cells. Int J Cancer, 58, 380-4.
14. Kikkawa F, Ishikawa H, Tamakoshi K, et al. 1995, Prognostic evaluation of lymphadenectomy for epithelial ovarian cancer. J Surg Oncol, 60, 227-31.
15. Nicholson LJ, Clarke JM, Pittilo RM, Machin SJ and Woolf N, 1984, The mesothelial cell as a non-thrombotic surface. Tromb Haemostas, 37, 108-14.
16. Wu YU, Parker LM, Binder NE, et al. 1982, The mesothelial keratins: a new family of cytoskeletal proteins identified in cultured mesothelial cells and nonkeratinizing epithelia. Cell, 31, 693-8.
17. Tamakoshi K, Kikkawa F, Nawa A, et al. 1994, Different pattern of zymography between human gynecologic normal and malignant tissues. Am J Obstet Gynecol, 171, 478-84.
18. Tamakoshi K, Kikkawa F, Nawa A, et al. 1995, Characterization of extracellular matrix degrading proteinases and its inhibitor in gynecologic cancer tissues with clinically different metastatic form. Cancer, 76, 2565-71.
19. Tryggvasion K, Hoyhtya M and Salo T, 1987, Proteolytic degradation of extracellular matrix in tumor invasion. Biochim Biophys Acta, 907, 191-217.
20. Murphy G, Cockett MI, Ward RV and Docherty AJ, 1991, Matrix metalloproteinase degradation of elastin, type IV collagen and proteoglycan. Biochem J, 277, 277-9.
21. Fabumi R, Baker A, Murray E, Booth R and Newby A, 1996, Divergent regulation by growth factors and cytokines of 95 kDa and 72 kDa gelatinase and tissue inhibitors or metalloproteinase-1, -2, and -3 in rabbit aortic smooth muscle cells. Biochem J, 315, 335-42.
22. Shimada I, Sasaguri Y, Kusukawa J, et al. 1993, Production of matrix metalloproteinase 9 (92-kDa gelatinase) by human oesophageal squamous cell carcinoma in response to epidermal growth factor. Br J Cancer, 67, 721-7.
23. Overall CM, Wanda JL and Sodek J, 1991, Transcriptional and post-transcriptional regulation of 72-kDa gelatinase/type IV collagenase by transforming growth factor-β1 in human fibroblasts. J Biol Chem, 21, 14064-71.
24. Ito A, Nakajima S, Sasaguri Y, Nagase H and Mori Y, 1995, Co-culture of human breast adenocarcinoma MCF-7 cells and human dermal fibroblasts enhances the production of matrix metalloproteinases 1, 2 and 3 in fibroblasts. Br J Cancer, 71, 1039-45.
25. Morikawa K, Walker SM, Nakajima M, et al. 1988, Influence of organ environment on the growth, selection, and metastasis of human colon carcinoma cells in nude mice. Cancer Res, 48, 6863-71.
26. Offner F, Obrist P, Stadimann S, et al. 1995, IL-6 secretion by human peritoneal and ovarian cancer cells. Cytokine, 7, 542-7.
27. Zeillermarker AM, Mul FP, Hoynck van papendrecht AA, et al. 1995, Polarized secretion of interleukin-8 by human mesothelial cells: a role in neutrophile migration. Immunology, 84, 227-32.
28. Langerak AW, van-der-Linden-van-Beurden CM and Versnel MA, 1996, Regulation of differential expression of platelet-derived growth factor alpha- and beta-receptor mRNA in normal and malignant human mesothelial cell lines. Biochim Biophys Acta, 1305, 63-70.
29. Cannistra SA, Ottensmeier C, Niloff J, Orta B and Dicarlo J, 1995, Expression and function of beta 1 and alpha v beta 3 integrins in ovarian cancer. Gynecol Oncol, 58, 216-25.
30. Jones LM, Gardner MJ, Catterall JB and Turner GA, 1995, Hyaluronic acid secreted by mesothelial cells: a natural barrier to ovarian cancer cell adhesion. Clin Exp Metastasis, 13, 373-80.
31. Engebraaten O, Bjerkvig R, Pedersen PH and Laerum OD, 1993, Effects of EGF, bFGF, NGF and PDGF(bb) on cell proliferative, migratory and invasive capacities of human brain-tumor biopsies in vitro. Int J Cancer, 53, 209-14.
32. Moriyama T, Kataoka H, Seguchi K, Tsubouchi H and Koono M, 1996, Effects of hepatocyte growth factor (HGF) on human glioma cells in vitro: HGF acts as a motility factor in glioma cells. Int J Cancer, 66, 678-85.